SCHEMBL4192525

SCHEMBL4192525

C[C@H](NCc1ccccc1NS(=O)(=O)c1ccc(-n2cncn2)cc1)[C@@H](O)C1CCCCC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.46
PKM P14618 1/20 0.46
LMNA P02545 6/20 0.38
POLB P06746 2/20 0.38
SMYD3 Q9H7B4 1/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
MAPT P10636 7/20 0.36
ALDH1A1 P00352 5/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
FPR1 P21462 2/20 0.34
TP53 P04637 2/20 0.33
NPSR1 Q6W5P4 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
DPP4 P27487 1/20 0.33
HTT P42858 2/20 0.33
THRB P10828 1/20 0.33
YTHDC1 Q96MU7 1/20 0.33
GAA P10253 1/20 0.33
CASP1 P29466 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4192521 1.00 KDM4E (0.46) KDM4EPKMLMNAPOLBSMYD3
SCHEMBL4193489 0.85 KDM4E (0.46) KDM4EPKMLMNAPOLBMEN1
SCHEMBL4196825 0.85 KDM4E (0.46) KDM4EPKMLMNAPOLBMEN1
SCHEMBL4185861 0.84 PKM (0.51) KDM4EPKMLMNAPOLBMEN1
SCHEMBL4185855 0.84 PKM (0.51) KDM4EPKMLMNAPOLBMEN1
SCHEMBL4188350 0.84 PKM (0.51) KDM4EPKMLMNAPOLBMEN1
SCHEMBL4188353 0.84 PKM (0.51) KDM4EPKMLMNAPOLBMEN1
SCHEMBL4189940 0.84 KDM4E (0.44) KDM4EPKMLMNAPOLBMEN1
SCHEMBL14343969 0.77 KDM4E (0.48) KDM4EPKMLMNAPOLBMEN1
SCHEMBL4189859 0.74 PKM (0.52) KDM4EPKMLMNAPOLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP claimed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US claimed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US claimed
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP disclosed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 KDM4E 3328/4885PKM 1855/4885LMNA 2332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.